Mark J Foley - Net Worth and Insider Trading
Mark J Foley Net Worth
The estimated net worth of Mark J Foley is at least $19 Million dollars as of 2024-04-29. Mark J Foley is the President and CEO of ZELTIQ Aesthetics Inc and owns about 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $12 Million. Mark J Foley is the CEO of Revance Therapeutics Inc and owns about 1,126,381 shares of Revance Therapeutics Inc (RVNC) stock worth over $4 Million. Mark J Foley is also the Director of Glaukos Corp and owns about 33,220 shares of Glaukos Corp (GKOS) stock worth over $3 Million. Details can be seen in Mark J Foley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark J Foley has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).
Transaction Summary of Mark J Foley
Mark J Foley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Foley owns 4 companies in total, including Revance Therapeutics Inc (RVNC) , SI-BONE Inc (SIBN) , and Glaukos Corp (GKOS) among others .
Click here to see the complete history of Mark J Foley’s form 4 insider trades.
Insider Ownership Summary of Mark J Foley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2024-03-06 | director |
| SIBN | SI-BONE Inc | 2019-06-13 | director |
| GKOS | Glaukos Corp | 2024-02-23 | director |
| ZLTQ | ZELTIQ Aesthetics Inc | 2017-04-28 | director & President and CEO |
Mark J Foley Latest Holdings Summary
Mark J Foley currently owns a total of 3 stocks. Among these stocks, Mark J Foley owns 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of March 13, 2017, with a value of $12 Million and a weighting of 61.76%. Mark J Foley owns 1,126,381 shares of Revance Therapeutics Inc (RVNC) as of March 6, 2024, with a value of $4 Million and a weighting of 21.64%. Mark J Foley also owns 33,220 shares of Glaukos Corp (GKOS) as of February 23, 2024, with a value of $3 Million and a weighting of 16.6%.
Latest Holdings of Mark J Foley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZLTQ | ZELTIQ Aesthetics Inc | 2017-03-13 | 211,454 | 56.48 | 11,942,922 |
| RVNC | Revance Therapeutics Inc | 2024-03-06 | 1,126,381 | 3.72 | 4,184,505 |
| GKOS | Glaukos Corp | 2024-02-23 | 33,220 | 96.63 | 3,209,883 |
Holding Weightings of Mark J Foley
Mark J Foley Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Foley has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 10,000 shares on March 13, 2017, which brought Mark J Foley around $557,700.
According to the SEC Form 4 filings, Mark J Foley has made a total of 7 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 30,000 shares on March 6, 2024, which cost Mark J Foley around $209,400.
According to the SEC Form 4 filings, Mark J Foley has made a total of 1 transactions in Glaukos Corp (GKOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Glaukos Corp is the sale of 4,560 shares on February 23, 2024, which brought Mark J Foley around $423,487.
Insider Trading History of Mark J Foley
- 1
Mark J Foley Trading Performance
GuruFocus tracks the stock performance after each of Mark J Foley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Foley is 18.09%. GuruFocus also compares Mark J Foley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Foley within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J Foley's insider trading performs compared to the benchmark.
Performance of Mark J Foley
Average Return
32.64%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.25 | 18.09 | 9.54 | 32.64 | -24.67 | -0.32 |
| Relative Return to S&P 500(%) | 6.02 | 20.08 | 13.3 | 35.82 | -28.67 | -10.97 |
Mark J Foley Ownership Network
Ownership Network List of Mark J Foley
Ownership Network Relation of Mark J Foley
Mark J Foley Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Mark J Foley is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Mark J Foley made 6 insider transaction in Revance Therapeutics Inc (RVNC) with a net sale of 194,674. Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 68,485 shares made by Tobin Schilke , a net sale of 82,875 shares made by Dwight Moxie , and a net sale of 56,734 shares made by Dustin S Sjuts .
In summary, during the past 3 months, insiders sold 29,089 shares of Revance Therapeutics Inc (RVNC) in total and bought 30,000 shares, with a net purchase of 911 shares. During the past 18 months, 437,660 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 407,660 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Mark J Foley Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Foley. You might contact Mark J Foley via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
